Tuesday, August 23, 2016

In Argentina, Ampligen has just been commercially approved for severe ME/CFS


  "“In Argentina, rintatolimod (Ampligen) has just been commercially approved for the severe disabling form of ME/CFS.  The number of patients with ME/CFS is estimated to be over three million worldwide, however, only a portion of these have the severe and disabling form of the disease which we are targeting with this drug,” stated Tom Equels."

  "Several post-approval activities are required to be completed before product launch, including manufacturing site inspections and reimbursement evaluation by the Health Services Authority (SSS), the central health authority in Argentina."


1 comment:

FeatherJack said...

Great blog, thanks. I just want to share a couple of great articles for doctors, family, friends and other skeptics.

The Faces Of ME: Missing 7 Years Of My Life –

Learning Firsthand About Chronic Fatigue Syndrome – http://nyti.ms/1as74hv

#StopTheStigma #ME #CFS #MillionsMissing #CureME


Related Posts with Thumbnails